📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV. (2022)

First Author: Corey RA

Attributed to: The Lipoprotein Biogenesis Pathway: An Emerging Structural Target for Novel Antibiotics funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d2sc04072g

PubMed Identifier: 36507170

Publication URI: http://europepmc.org/abstract/MED/36507170

Type: Journal Article/Review

Volume: 13

Parent Publication: Chemical science

Issue: 45

ISSN: 2041-6520